Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy
Open Access
- 31 August 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 123 (8), 719-726
- https://doi.org/10.1016/j.amjmed.2010.02.014
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysisEuropean Heart Journal, 2009
- Effect of Very High-Intensity Statin Therapy on Regression of Coronary AtherosclerosisJAMA, 2006
- Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trialJournal of the American College of Cardiology, 2004
- A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery DiseaseJAMA, 2003
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsThe Lancet, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trialsThe Lancet, 1999
- Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertensionJournal of the American College of Cardiology, 1998
- Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?JAMA, 1998